Phase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImplantation Factor (sPIF) in Patients With Autoimmune Hepatitis (AIH)
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2019
Price : $35 *
At a glance
- Drugs Preimplantation factor (Primary)
- Indications Autoimmune hepatitis
- Focus Adverse reactions; Pharmacokinetics
- 31 Dec 2018 Planned initiation date changed from 1 Nov 2018 to 1 Jan 2019.
- 31 Dec 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 26 Jul 2018 New trial record